GUNVANT N MEHTA
Pharmacy in Lansdale, PA
License number
Pennsylvania PI090418L
Category
Pharmacy
Type
Pharmacy Intern
Address
Address
Lansdale, PA 19446
Personal information
See more information about GUNVANT N MEHTA at radaris.comName
Address
Phone
1425 Gwynedale Way, Lansdale, PA 19446
Lansdale, PA
1425 Gwynedale Way, Lansdale, PA 19446
104 Coventry Cir, Lansdale, PA 19446
10 Curry Ln, Horsham, PA 19044
Professional information
Sustained Release Indomethacin
US Patent:
4173626, Nov 6, 1979
Filed:
Dec 11, 1978
Appl. No.:
5/968608
Inventors:
Robert E. Dempski - Dresher PA
Gunvant N. Mehta - Lansdale PA
Joseph C. Saboe - Norristown PA
Gunvant N. Mehta - Lansdale PA
Joseph C. Saboe - Norristown PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 922, A61K 948
US Classification:
424 19
Abstract:
A sustained release indomethacin pharmaceutical product is provided that utilizes a pellet formulation encapsulated in a hard gelatin capsule. A portion of the pellets is uncoated for immediate and rapid release of indomethacin for elevating the plasma level. The remainder of the pellets are coated with a polymer to sustain the plasma level. The uncoated and coated pellets may be mixed with non-medicated pellets as a capsule filler.
Solid State Ophthalmic Medication
US Patent:
4179497, Dec 18, 1979
Filed:
Nov 13, 1978
Appl. No.:
5/959550
Inventors:
Edward M. Cohen - Beaumont, FR
Wayne M. Grim - Doylestown PA
Richard J. Harwood - Philadelphia PA
Gunvant N. Mehta - Lansdale PA
Wayne M. Grim - Doylestown PA
Richard J. Harwood - Philadelphia PA
Gunvant N. Mehta - Lansdale PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 922, A61K 926
US Classification:
424 22
Abstract:
Solid unit dosage medicaments which are suitable for use in animals and humans are prepared with hydroxypropyl cellulose as the primary formulating excipient. These medicaments are particularly suitable for ophthalmic use since they are slowly but completely water soluble when they are inserted in the cul-de-sac of the eye and thus provide for a convenient means of prolonged treatment of the eye with concomitant reduced dosing frequency.
Method For The Preparation Of A Theophylline Sustained Release Pharmaceutical Composition And The Composition Prepared Thereby
US Patent:
5026709, Jun 25, 1991
Filed:
Jun 7, 1988
Appl. No.:
7/203435
Inventors:
Richard J. Harwood - Bensalem PA
Gunvant N. Mehta - Lansdale PA
Ramesh C. Jhawar - Yardley PA
Liang-Lii Huang - Maple Glen PA
Wayne M. Grim - Doylestown PA
Shun P. Li - Upper Darby PA
Gunvant N. Mehta - Lansdale PA
Ramesh C. Jhawar - Yardley PA
Liang-Lii Huang - Maple Glen PA
Wayne M. Grim - Doylestown PA
Shun P. Li - Upper Darby PA
Assignee:
Rorer Pharmaceutical Corporation - Fort Washington PA
International Classification:
A01N 4390, A01K 3152
US Classification:
514263
Abstract:
A method for the preparation of a sustained release pharmaceutical composition comprising forming a fluidized ring of said particles and contacting said particles maintained suspended in said ring with a liquid composition containing a pharmaceutically active material and an alkali-soluble material.